Supernus SUPN
NASDAQ SUPN
$28.75 +1.13 (+4.09%)
As of: Nov 10, 2026 · 3:52 PM EST

Supernus (SUPN) Receivables - Other (2024 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) reported Receivables - Other of $4.7 million for Q3 2026, down 25.4% from $6.3 million a year earlier but up 9.3% from the prior quarter.

Analysis

Supernus (SUPN) Receivables - Other (2024 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals posted Receivables - Other of $1.8 million, down 55.0% from FY2024.

  • By year, Receivables - Other came in at $4 million in FY2024.
  • Five-year quarterly Receivables - Other spans a low of $1.8 million in Q4 2025 and a high of $6.3 million in Q3 2025.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $4.3 million (Q2 2026), $1.9 million (Q1 2026) and $1.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Supernus 1.62 Bn 196.50 Mn 199.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.70 Mn
Jun 30, 2026 4.30 Mn
Mar 31, 2026 1.90 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 6.30 Mn
Jun 30, 2025 5.40 Mn
Dec 31, 2024 4.00 Mn
API Access

Supernus Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SUPN&period=max&api_key=YOUR_API_KEY